Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Ensor

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|December 24, 2016
Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantationChristopher R Ensor, Lindsey C Rihtarchik, Matthew R Morrell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 28, 2020
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunctionCarlo J Iasella, Christopher R Ensor, Marilyn Marrari, et al.
The Annals of Pharmacotherapy|April 26, 2017
Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery SystemJames C Coons, Carlo J Iasella, Tyler Chanas, et al.
Transplantation|July 11, 2017
Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin InhibitorsCarlo J Iasella, Ryan J Winstead, Cody A Moore, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 3, 2014
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantationMatthew R Morrell, Joseph M Pilewski, Cynthia J Gries, et al.
Journal of Cardiac Failure|May 14, 2013
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkSherry K Milfred-Laforest, Sheryl L Chow, Robert J Didomenico, et al.
Pharmacotherapy|May 8, 2013
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkSherry K Milfred-LaForest, Sheryl L Chow, Robert J DiDomenico, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 10, 2019
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLTGeert M Verleden, Allan R Glanville, Erika D Lease, et al.
Open Forum Infectious Diseases|October 13, 2021
Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung InjuryDavide Ventura, Amy L Carr, R Duane Davis, et al.
JACC. Heart Failure|October 22, 2025
Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes RegistryPaul J Kim, Amit H Alam, Jeffrey J Teuteberg, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|December 24, 2016
Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantationChristopher R Ensor, Lindsey C Rihtarchik, Matthew R Morrell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 28, 2020
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunctionCarlo J Iasella, Christopher R Ensor, Marilyn Marrari, et al.
The Annals of Pharmacotherapy|April 26, 2017
Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery SystemJames C Coons, Carlo J Iasella, Tyler Chanas, et al.
Transplantation|July 11, 2017
Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin InhibitorsCarlo J Iasella, Ryan J Winstead, Cody A Moore, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 3, 2014
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantationMatthew R Morrell, Joseph M Pilewski, Cynthia J Gries, et al.
Journal of Cardiac Failure|May 14, 2013
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkSherry K Milfred-Laforest, Sheryl L Chow, Robert J Didomenico, et al.
Pharmacotherapy|May 8, 2013
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkSherry K Milfred-LaForest, Sheryl L Chow, Robert J DiDomenico, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 10, 2019
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLTGeert M Verleden, Allan R Glanville, Erika D Lease, et al.
Open Forum Infectious Diseases|October 13, 2021
Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung InjuryDavide Ventura, Amy L Carr, R Duane Davis, et al.
JACC. Heart Failure|October 22, 2025
Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes RegistryPaul J Kim, Amit H Alam, Jeffrey J Teuteberg, et al.
Pageof 6